Back to calendar
Xilio Therapeutics, Inc. (XLO) Earnings
XLO reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.82
Actual EPS: $-0.33
EPS surprise: 44.07%
Company overview
Market Cap$59.2M
PriceUSD 9.00
EPS (TTM)-1.69
52-week high12.74
52-week low6.47
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees76